|
HY-116814-5mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116814-50mg
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116814-1mL
|
MedChemexpress LLC
|
ML401 [CAS 1597489-14-9] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128121-10mg
|
MedChemexpress LLC
|
MLS1547 [CAS 315698-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128121-100mg
|
MedChemexpress LLC
|
MLS1547 [CAS 315698-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128121-25mg
|
MedChemexpress LLC
|
MLS1547 [CAS 315698-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128121-50mg
|
MedChemexpress LLC
|
MLS1547 [CAS 315698-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128121-5mg
|
MedChemexpress LLC
|
MLS1547 [CAS 315698-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128121-1mL
|
MedChemexpress LLC
|
MLS1547 [CAS 315698-36-3] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12220-10mg
|
MedChemexpress LLC
|
MM-102 [CAS 1417329-24-8]
|
|
Cancer-programmed cell death
|
|
|
HY-12220-2mg
|
MedChemexpress LLC
|
MM-102 [CAS 1417329-24-8]
|
|
Cancer-programmed cell death
|
|
|
HY-12220-5mg
|
MedChemexpress LLC
|
MM-102 [CAS 1417329-24-8]
|
|
Cancer-programmed cell death
|
|
|
HY-12220-50mg
|
MedChemexpress LLC
|
MM-102 [CAS 1417329-24-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153612-1mg
|
MedChemexpress LLC
|
MMV009085 [CAS 298217-59-1]
|
|
|
|
|
HY-153612-10mg
|
MedChemexpress LLC
|
MMV009085 [CAS 298217-59-1]
|
|
|
|
|
HY-153612-5mg
|
MedChemexpress LLC
|
MMV009085 [CAS 298217-59-1]
|
|
|
|
|
HY-147112-250mg
|
MedChemexpress LLC
|
MNP-GAL [CAS 70622-78-5]
|
|
|
|
